Miniaturization of mechanical circulatory support systems

Artificial Organs

Volumn 36, Issue 8, 2012, Pages 731-739

  Giridharan, Guruprasad A ^a   Lee, Thomas J ^a   Ising, Mickey ^a   Sobieski, Michael A ^a   Koenig, Steven C ^a   Gray, Laman A ^a   Slaughter, Mark S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Heart failure; Mechanical circulatory support; Miniaturization; Review; Ventricular assist device technology

Indexed keywords

CARDIOLOGY; DIAGNOSIS; ENERGY TRANSFER; FIBER OPTIC SENSORS; HEART; LEFT VENTRICULAR ASSIST DEVICES; MOLECULAR BIOLOGY; PATIENT TREATMENT;

DEVICE TECHNOLOGIES; HEALTH CARE COSTS; HEALTHCARE RESOURCES; HEART FAILURE; MECHANICAL CIRCULATORY SUPPORT; MECHANICAL CIRCULATORY SUPPORT DEVICE; MECHANICAL CIRCULATORY SUPPORT SYSTEM; MINIATURISATION; VENTRICULAR ASSIST DEVICE; VENTRICULAR ASSIST DEVICE TECHNOLOGY;

MINIATURE INSTRUMENTS;

DACRON;

ARTICLE; ASSISTED CIRCULATION; BLOOD COMPONENT THERAPY; CARDIOPULMONARY BYPASS; ELECTRONICS; HEALTH CARE COST; HEART FAILURE; HUMAN; MEDICAL DEVICE; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; QUALITY OF LIFE;

EID: 84864795993     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2012.01523.x     Document Type: Article

References (74)

1. Roger VL, Go AS, Lloyd-Jones DM, etal. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012;125:188.
2. Muntwyler J, Abetel G, Gruner C, Follath F. One-year mortality among unselected outpatients with heart failure. Eur Heart J 2002;23:1861-6.
3. Pitt B, Zannad F, Remme WJ, etal. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
4. Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients. OPTN/SRTR 2010 Annual Data Report Rockville, MD: US Department of Health and Human Services, 2011.
5. Canadian Institute for Health Information. Report on Transplant, Waiting List and Donor Statistics, in 2008 Summary Statistics (Jan 1-Dec 31, 2008) Ottawa, ON: CIHI.
6. Japan Organ Transplant Network. Donors and Transplants Data (Jan 1-Dec 31, 2008). Tokyo: JOTN, 2008.
7. Gregoric ID, La Francesca S, Myers T, etal. A less invasive approach to axial flow pump insertion. J Heart Lung Transplant 2008;27:423-6.
8. Frazier O, Gregoric ID, Cohn WE. Initial experience with non-thoracic, extraperitoneal, off-pump insertion of the Jarvik 2000 Heart in patients with previous median sternotomy. J Heart Lung Transplant 2006;25:499-503.
9. Kirklin JK, Naftel DC, Kormos RL, etal. Second INTERMACS annual report: more than 1000 primary left ventricular assist device implants. J Heart Lung Transplant 2010;29:1-10.
10. Birks EJ, Tansley PD, Hardy J, etal. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355:1873-84.
11. Shinn JA. Novacor left ventricular assist system. AACN Adv Crit Care 1991;2:575.
12. Martin J, Friesewinkel O, Benk C, Sorg S, Schultz S, Beyersdorf F. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year. J Heart Lung Transplant 2006;25:384-90.
13. Slaughter MS, Tsui SS, El-Banayosy A, etal. Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device. J Thorac Cardiovasc Surg 2007;133:1573-80. e2.
14. Griffith BP, Kormos RL, Borovetz HS, etal. HeartMate II left ventricular assist system: from concept to first clinical use. Ann Thorac Surg 2001;71:S116-20.
15. LaRose JA, Tamez D, Ashenuga M, Reyes C. Design concepts and principle of operation of the heartware ventricular assist system. ASAIO J 2010;56:285.
16. Noon GP, Morley D, Irwin S, Benkowski R. Development and clinical application of the MicroMed DeBakey VAD. Curr Opin Cardiol 2000;15:166.
17. Frazier O, Myers TJ, Jarvik RK, etal. Research and development of an implantable, axial-flow left ventricular assist device: the Jarvik 2000 Heart. Ann Thorac Surg 2001;71:S125-32.
18. Slaughter MS, Rogers JG, Milano CA, etal. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-51.
19. Burgreen GW, Loree HM, Bourque K, etal. Computational fluid dynamics analysis of a maglev centrifugal left ventricular assist device. Artif Organs 2004;28:874-80.
20. Song X, Throckmorton AL, Wood HG, Allaire PE, Olsen DB. Transient and quasi-steady computational fluid dynamics study of a left ventricular assist device. ASAIO J 2004;50:410.
21. Lodge AJ, Antunez AG, Jaquiss RDB. Pediatric ventricular assist devices. Prog Pediatr Cardiol 2012;3:82-86.
22. Baldwin JT, Borovetz HS, Duncan BW, etal. The National Heart, Lung, and Blood Institute pediatric circulatory support program. Circulation 2006;113:147-55.
23. Slaughter MS, Sobieski MA II, Tamez D, etal. HeartWare miniature axial-flow ventricular assist device: design and initial feasibility test. Tex Heart Inst J 2009;36:12.
24. Thoratec. A new era in the treatment of advanced heart failure. In the 29th Annual J.P. Morgan Healthcare Conference. 2011.
25. Frazier O, Myers TJ, Gregoric ID, etal. Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation 2002;105:2855-60.
26. Henriques JPS, Remmelink M, Baan J, etal. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol 2006;97:990-2.
27. Prondzinsky R, Lemm H, Swyter M, etal. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010;38:152.
28. Ohman EM, George BS, White CJ, etal. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. Circulation 1994;90:792-9.
29. Jayakar DV. Surgical treatment for chronic heart failure. Compr Ther 2003;29:66-76.
30. Mitnovetski S, Almeida AA, Barr A, etal. Extra-aortic implantable counterpulsation pump in chronic heart failure. Ann Thorac Surg 2008;85:2122-5.
31. Hayward CS, Peters WS, Merry AF, etal. Chronic extra-aortic balloon counterpulsation: first-in-human pilot study in end-stage heart failure. J Heart Lung Transplant 2010;29:1427-32.
32. Jeevanandam V, Jayakar D, Anderson AS, etal. Circulatory assistance with a permanent implantable IABP: initial human experience. Circulation 2002;106(12 Suppl. 1):I-183-188.
33. Terrovitis JV, Charitos CE, Tsolakis EJ, etal. Superior performance of a paraaortic counterpulsation device compared to the intraaortic balloon pump. World J Surg 2003;27:1311-6.
34. Legget ME, Peters WS, Milson FP, etal. Extra-aortic balloon counterpulsation. Circulation 2005;112(9 Suppl.):I-26-31.
35. Koenig SC, Litwak KN, Giridharan GA, etal. Acute hemodynamic efficacy of a 32-ml subcutaneous counterpulsation device in a calf model of diminished cardiac function. ASAIO J 2008. 54:578.
36. Giridharan GA, Pantalos GM, Litwak KN, Spence PA, Koenig SC. Predicted hemodynamic benefits of counterpulsation therapy using a superficial surgical approach. ASAIO J 2006. 52:39.
37. Bartoli CR, Wilson GC, Giridharan GA, etal. A novel subcutaneous counterpulsation device: acute hemodynamic efficacy during pharmacologically induced hypertension, hypotension, and heart failure. Artif Organs 2010;34:537-45.
38. Giridharan G, Lederer C, Berthe A, etal. Flow dynamics of a novel counterpulsation device characterized by CFD and PIV modeling. Med Eng Phys 2011;33:1193-202.
39. Babu R, Gill R, Farrar D. Biostability of Thoralon left ventricular assist device blood pumping sacs after long-term clinical use. ASAIO J 2004;50:479.
40. Wagner WR, Johnson PC, Heil BV, Thompson KA, Kormos RL, Griffith BP. Thrombin activity resides on LVAD Dacron inflow and outflow grafts. ASAIO J 1992;38:M634.
41. Akhter SA, Raman J, Jeevanandam V. Technique for left ventricular apical cannulation for short-term mechanical circulatory support. Ann Thorac Surg 2010;89:994-5.
42. Minami K, El-Banayosy A, Sezai A, etal. Morbidity and outcome after mechanical ventricular support using Thoratec, Novacor, and HeartMate for bridging to heart transplantation. Artif Organs 2000;24:421-6.
43. Korakianitis T, Shi Y. Numerical comparison of hemodynamics with atrium to aorta and ventricular apex to aorta VAD support. ASAIO J 2007;53:537.
44. Litwak KN, Koenig SC, Cheng RC, Giridharan GA, Gillars KJ, Pantalos GM. Ascending aorta outflow graft location and pulsatile ventricular assist provide optimal hemodynamic support in an adult mock circulation. Artif Organs 2005;29:629-35.
45. Vlachopoulos C, Mcdonald P, Spratt P, O'Rourke M. Pulse wave analysis in the assessment of patients with left ventricular assist device. J Heart Lung Transplant 2001;20:98-102.
46. Litwak KN, Koenig SC, Tsukui H, Kihara S, Wu Z, Pantalos GM. Effects of left ventricular assist device support and outflow graft location upon aortic blood flow. ASAIO J 2004;50:432.
47. Slaughter MS, Giridharan GA, Tamez D, etal. Transapical miniaturized ventricular assist device: design and initial testing. J Thorac Cardiovasc Surg 2011;142:668-74.
48. Frazier O. First use of an untethered, vented electric left ventricular assist device for long-term support [published erratum appears in Circulation 1995 Jun 15; 91 (12): 3026]. Circulation 1994;89:2908-14.
49. Frazier O, Myers TJ. Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg 1999;68:734-41.
50. Frazier O. Evolution of battery-powered, vented left ventricular assist devices. Ann Thorac Surg 1996;61:393-5.
51. Siegenthaler M, Martin J, Pernice K, etal. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device. Eur J Cardiothorac Surg 2003;23:748-55.
52. Slaughter MS, Myers TJ. Transcutaneous energy transmission for mechanical circulatory support systems: history, current status, and future prospects. J Card Surg 2010;25:484-9.
53. Slaughter MS, Ising MS, Tamez D, etal. Increase in circadian variation after continuous-flow ventricular assist device implantation. J Heart Lung Transplant 2010;29:695-7.
54. Giridharan GA, Skliar M. Physiological control of blood pumps using intrinsic pump parameters: a computer simulation study. Artif Organs 2006;30:301-7.
55. Giridharan GA, Skliar M. Control strategy for maintaining physiological perfusion with rotary blood pumps. Artif Organs 2003;27:639-48.
56. Vollkron M, Schima H, Huber L, Benkowski R, Morello G, Wieselthaler G. Development of a suction detection system for axial blood pumps. Artif Organs 2004;28:709-16.
57. Voigt O, Benkowski RJ, Morello GF. Suction detection for the MicroMed DeBakey left ventricular assist device. ASAIO J 2005;51:321.
58. Slaughter MS, Bartoli CR, Sobieski MA, etal. Intraoperative evaluation of the HeartMate II flow estimator. J Heart Lung Transplant 2009;28:39-43.
59. Burke DJ, Burke E, Parsaie F, etal. The Heartmate II: design and development of a fully sealed axial flow left ventricular assist system. Artif Organs 2001;25:380-5.
60. Mehta SM, Pae WE, Rosenberg G, etal. The LionHeart LVD-2000: a completely implanted left ventricular assist device for chronic circulatory support. Ann Thorac Surg 2001;71:S156-61.
61. Zhang F, Liu X, Hackworth SA, Sclabassi RJ, Sun M. In vitro and in vivo studies on wireless powering of medical sensors and implantable devices. 2009. IEEE.
62. Waters BH, Sample AP, Bonde P, Smith J. Powering a ventricular assist device (VAD) with the free-range resonant electrical energy delivery (FREE-D) system. Proc IEEE 2012;100:1-12.
63. Feller ED, Sorensen EN, Haddad M, etal. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients. Ann Thorac Surg 2007;83:1082-8.
64. Bomholt T, Moser C, Sander K, etal. Driveline infections in patients supported with a HeartMate II: incidence, aetiology and outcome. Scand Cardiovasc J 2011;45:273-8.
65. Holman WL, Park SJ, Long JW, etal. Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant 2004;23:1359-65.
66. Tigges-Limmer K, Schönbrodt M, Roefe D, Arusoglu L, Morshuis M, Gummert JF. Suicide after ventricular assist device implantation. J Heart Lung Transplant 2010;29:692-4.
67. Rogers JG, Aaronson KD, Boyle AJ, Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 2010;55:1826-34.
68. Frazier O, Gemmato C, Myers TJ, etal. Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. Tex Heart Inst J 2007;34:275.
69. Drakos SG, Janicki L, Horne BD, etal. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol 2010;105:1030-5.
70. Topkara VK, Dang NC, Barili F, etal. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant 2006;25:404-8.
71. Woo YJ, Acker MA. Implantable ventricular assist device exchange with focused intravascular deairing techniques. Ann Thorac Surg 2011;91:306-7.
72. Goldstein AH, Monreal G, Kambara A, etal. Partial support with a centrifugal left ventricular assist device reduces myocardial oxygen consumption in chronic, ischemic heart failure. J Card Fail 2005;11:142-51.
73. Reinlib L, Abraham W. Recovery from heart failure with circulatory assist: a working group of the National Heart, Lung, and Blood Institute. J Card Fail 2003;9:459-63.
74. Kirklin JK, Naftel DC, Kormos RL, etal. The Fourth INTERMACS Annual Report: 4000 implants and counting. J Heart Lung Transplant 2012;31:117-26.